立体定向体部放疗和立体定向放射治疗中的间接细胞死亡与线性二次模型
Indirect cell death and the LQ model in SBRT and SRS.
作者信息
Song Chang W, Terezakis Stephanie, Emami Bahman, Griffin Robert J, Sperduto Paul W, Kim Mi-Sook, Cho L Chinsoo
机构信息
Department of Radiation Oncology, University of Minnesota Medical School, Minneapolis, MN, USA.
Department of Radiation Oncology, Loyola University Medical Center Chicago, IL, USA.
出版信息
J Radiosurg SBRT. 2020;7(1):1-4.
Abstract
High-dose hypofractionated SBRT and SRS indirectly kills substantial fractions of tumor cells via causing vascular damage. The LQ formula may work well for certain clinical cases of SBRT and SRS when the indirect/additional tumor cell death secondary to vascular damage is small. However, when the indirect cell death is extensive, the LQ model will underestimate the clinical outcome of SBRT and SRS.
摘要
高剂量低分割立体定向体部放疗（SBRT）和立体定向放射外科治疗（SRS）通过引起血管损伤间接杀死大量肿瘤细胞。当血管损伤继发的间接/额外肿瘤细胞死亡较小时，线性二次（LQ）公式可能适用于SBRT和SRS的某些临床病例。然而，当间接细胞死亡广泛时，LQ模型将低估SBRT和SRS的临床疗效。
相似文献
1
Indirect cell death and the LQ model in SBRT and SRS.
J Radiosurg SBRT. 2020;7(1):1-4.
2
Radiobiological basis of SBRT and SRS.
Int J Clin Oncol. 2014 Aug;19(4):570-8. doi: 10.1007/s10147-014-0717-z. Epub 2014 Jul 5.
3
Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery.
Radiat Oncol J. 2015 Dec;33(4):265-75. doi: 10.3857/roj.2015.33.4.265. Epub 2015 Dec 30.
4
Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS).
Radiat Res. 2012 Mar;177(3):311-27. doi: 10.1667/rr2773.1. Epub 2012 Jan 9.
5
A Model of Indirect Cell Death Caused by Tumor Vascular Damage after High-Dose Radiotherapy.
Cancer Res. 2019 Dec 1;79(23):6044-6053. doi: 10.1158/0008-5472.CAN-19-0181. Epub 2019 Oct 22.
6
The radiobiological targets of SBRT: tumor cells or endothelial cells?
Ann Transl Med. 2015 Nov;3(19):290. doi: 10.3978/j.issn.2305-5839.2015.09.17.
7
Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):847-52. doi: 10.1016/j.ijrobp.2007.10.059.
8
Comparison of Three Radiobiological Models in Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer.
J Cancer. 2019 Aug 8;10(19):4655-4661. doi: 10.7150/jca.33001. eCollection 2019.
9
MO-A-BRB-02: Facts and Fiction of Flattening Filter Free (FF-FFF) X-Rays Beams.
Med Phys. 2012 Jun;39(6Part20):3861-3862. doi: 10.1118/1.4735765.
10
NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction.
Acta Oncol. 2011 May;50(4):518-27. doi: 10.3109/0284186X.2010.543695. Epub 2011 Jan 4.
引用本文的文献
1
Investigation of Normal Tissue Toxicity in Pulsed Low Dose Rate Radiotherapy.
Cancers (Basel). 2025 May 19;17(10):1701. doi: 10.3390/cancers17101701.
2
Radiation-induced senescence: therapeutic opportunities.
Radiat Oncol. 2023 Jan 13;18(1):10. doi: 10.1186/s13014-022-02184-2.
3
The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
Med Phys. 2022 Dec;49(12):7672-7682. doi: 10.1002/mp.15911. Epub 2022 Aug 19.
4
Technical Note: Break-even dose level for hypofractionated treatment schedules.
Med Phys. 2021 Nov;48(11):7534-7540. doi: 10.1002/mp.15267. Epub 2021 Oct 22.
本文引用的文献
1
Reoxygenation and Repopulation of Tumor Cells after Ablative Hypofractionated Radiotherapy (SBRT and SRS) in Murine Tumors.
Radiat Res. 2019 Aug;192(2):159-168. doi: 10.1667/RR15346.1. Epub 2019 Jun 12.
2
Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death.
Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):21-34. doi: 10.1016/j.ijrobp.2019.02.047. Epub 2019 Mar 2.
3
The Biology of SBRT: LQ or Something New?
Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):964. doi: 10.1016/j.ijrobp.2018.02.038. Epub 2018 Mar 6.
4
Tumour Vascular Shutdown and Cell Death Following Ultrasound-Microbubble Enhanced Radiation Therapy.
Theranostics. 2018 Jan 1;8(2):314-327. doi: 10.7150/thno.19010. eCollection 2018.
5
A hypothesis: indirect cell death in the radiosurgery era.
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):11-3. doi: 10.1016/j.ijrobp.2014.08.355.
6
Is indirect cell death involved in response of tumors to stereotactic radiosurgery and stereotactic body radiation therapy?
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):924-5. doi: 10.1016/j.ijrobp.2014.03.043.
7
The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?
Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):254-62. doi: 10.1016/j.ijrobp.2013.07.022.
8
Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer.
Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1159-60. doi: 10.1016/j.ijrobp.2012.11.003.
9
Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS).
Radiat Res. 2012 Mar;177(3):311-27. doi: 10.1667/rr2773.1. Epub 2012 Jan 9.
10
A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy.
Sci Transl Med. 2010 Jul 7;2(39):39ra48. doi: 10.1126/scitranslmed.3000864.
Zotero 插件